This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
Established in 1992, the 340B Drug Pricing Program has many nuances and applications to different si...
In 2016, the term “materiality” as it relates to the False Claims Act made a splash in t...
This course will provide a detailed overview of the Medicare Secondary Payer act as well as provide ...
AI is impacting virtually every corner of practicing law. Increasing AI usage has revealed myriad ri...
This program will address the ethical obligations of Lawyer Advocates representing clients in arbitr...
Disasters, whether natural or manmade, happen. Disasters can impact the practice of law and, among o...
The “Chaptering Your Cross” program explains how dividing a cross?examination into clear...
AI, an innovative technology that was once a supporting act for digital transformation, business str...
Explore the transformative potential of generative AI in modern litigation. “Generative AI for...
In an era of heightening geopolitical tension, the protection of sensitive personal data has moved f...